Skip to content

Semaglutide

Semaglutide is a GLP-1 receptor agonist primarily used for weight management and type 2 diabetes treatment. It works by enhancing insulin secretion, reducing appetite, and slowing gastric emptying, which can lead to significant weight loss. Its role in longevity and health optimization is linked to its potential to improve metabolic health and reduce obesity-related risks.

Member access required

Clinical protocols and outcomes data are available to AXIFI Members and Providers.